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Coronavirus disease in 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic^1^. COVID-19 was first reported in Wuhan, China, in December 2019, among a group of individuals presenting with atypical pneumonia of unknown etiology^2^. Published data suggests that patients with a history of or active malignancy are at increased risk of infection and developing COVID-19 related complications^3,4^. Data from China have shown that cancer patients infected with COVID-19 are at 3.5 times the risk of requiring mechanical ventilation or intensive care unit (ICU) admission, compared to the general population^3^. In a recent cohort study, 928 cancer patients (39% were on active anticancer treatment, and 43% had active cancer) were analyzed, with a 30-day all-cause mortality of 13%, associated with general risk factors and risk factors unique to patients with cancer^1^.
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